Search Results
Matches for acronym pt
302
rows returned
Results are ranked by score and user rating. Use the quick vote buttons when a candidate clearly matches or clearly does not.
| Acronym | Full Name | Score | User Rating | Judge | Search |
|---|---|---|---|---|---|
| pt | prothrombin time | 285 | 2 |
|
|
| pt | pertussis toxin | 156 | -1 |
|
|
| pt | proximal tubule | 34 | 8 |
|
|
| pt | platinum | 34 | 1 |
|
|
| pt | pars tuberalis | 27 | 13 |
|
|
| pt | phage type | 23 | 2 |
|
|
| pt | permeability transition | 22 | 12 |
|
|
| pt | peak torque | 21 | 6 |
|
|
| pt | proximal tubular | 19 | 17 |
|
|
| pt | pyramidal tract | 19 | 8 |
|
|
| pt | Physical Therapy | 19 | 2 |
|
|
| pt | proficiency testing | 17 | 4 |
|
|
| pt | patellar tendon | 12 | 7 |
|
|
| pt | planum temporale | 12 | 2 |
|
|
| pt | prothrombin | 10 | 9 |
|
|
| pt | preterm | 8 | 66 |
|
|
| pt | primary thrombocythaemia | 7 | 4 |
|
|
| pt | pulmonary tuberculosis | 7 | 3 |
|
|
| pt | pulmonary trunk | 6 | 2 |
|
|
| pt | patient | 5 | 8 |
|
|
| pt | post-treatment | 5 | 5 |
|
|
| pt | pressure | 5 | 4 |
|
|
| pt | pregnanetriol | 5 | 2 |
|
|
| pt | ptaquiloside | 4 | 9 |
|
|
| pt | patients | 4 | 8 |
|
|
| pt | precipitin test | 3 | 14 |
|
|
| pt | pathologic tumor | 3 | 10 |
|
|
| pt | physical training | 3 | 9 |
|
|
| pt | penetrating trauma | 3 | 9 |
|
|
| pt | patch test | 3 | 9 |
|
|
| pt | Physical Therapist | 3 | 7 |
|
|
| pt | primary thrombocythemia | 3 | 7 |
|
|
| pt | phyllodes tumor | 3 | 6 |
|
|
| pt | primary tumour | 3 | 3 |
|
|
| pt | prick-tests | 3 | 1 |
|
|
| pt | pain threshold | 2 | 13 |
|
|
| pt | popliteal tendon | 2 | 11 |
|
|
| pt | pressure triggering | 2 | 10 |
|
|
| pt | peptic-tryptic | 2 | 9 |
|
|
| pt | patch tests | 2 | 9 |
|
|
| pt | Preference Test | 2 | 9 |
|
|
| pt | Stage | 2 | 8 |
|
|
| pt | power | 2 | 8 |
|
|
| pt | perception threshold | 2 | 7 |
|
|
| pt | protein turnover | 2 | 7 |
|
|
| pt | pertussis | 2 | 5 |
|
|
| pt | pathologic tumor stage | 2 | 4 |
|
|
| pt | physiological toxicokinetic | 2 | 3 |
|
|
| pt | proximal | 2 | 3 |
|
|
| pt | post-transplant | 2 | 3 |
|
|
| pt | provocation tests | 2 | 3 |
|
|
| pt | phototherapy | 2 | 2 |
|
|
| pt | pulmonary thromboembolism | 2 | 2 |
|
|
| pt | pars tensa | 2 | 1 |
|
|
| pt | pronator teres | 2 | 1 |
|
|
| pt | pure tone threshold | 2 | 0 |
|
|
| pt | pyrantel tartrate | 2 | 0 |
|
|
| pt | plasma platinum | 2 | -1 |
|
|
| pt | pretectum | 2 | -1 |
|
|
| pt | podophyllotoxin | 2 | -2 |
|
|
| pt | prematurely | 2 | -2 |
|
|
| pt | photothermal | 2 | -2 |
|
|
| pt | paralytic tremor | 2 | -2 |
|
|
| pt | protamine | 2 | -2 |
|
|
| pt | positive and negative transmural pressure | 1 | 67 |
|
|
| pt | parataenial | 1 | 17 |
|
|
| pt | percent were on phytotherapy | 1 | 14 |
|
|
| pt | picrotoxin | 1 | 13 |
|
|
| pt | pertussigen (pertussis toxin) | 1 | 13 |
|
|
| pt | post-transfusion | 1 | 13 |
|
|
| pt | penile tumescence | 1 | 13 |
|
|
| pt | premature | 1 | 13 |
|
|
| pt | primary tumor | 1 | 12 |
|
|
| pt | peripheral transmission | 1 | 12 |
|
|
| pt | prepared by enzymatic joining of d | 1 | 12 |
|
|
| pt | previously well-characterized antisera | 1 | 12 |
|
|
| pt | piretanide | 1 | 12 |
|
|
| pt | pathological stages | 1 | 12 |
|
|
| pt | pyramidal tract lesions | 1 | 12 |
|
|
| pt | performance of predictive-toxicology | 1 | 11 |
|
|
| pt | preemptive treatment | 1 | 11 |
|
|
| pt | positive threshold | 1 | 11 |
|
|
| pt | physiologic | 1 | 11 |
|
|
| pt | post-traumatic | 1 | 10 |
|
|
| pt | platelet prothrombinase | 1 | 10 |
|
|
| pt | post-transplantation | 1 | 10 |
|
|
| pt | pulse therapy | 1 | 10 |
|
|
| pt | PL maximum isometric twitch tension | 1 | 10 |
|
|
| pt | partial thromboplastin | 1 | 10 |
|
|
| pt | peptic-tryptic digest | 1 | 10 |
|
|
| pt | plus physiotherapy | 1 | 10 |
|
|
| pt | purge-and-trap | 1 | 10 |
|
|
| pt | posterior thalamus | 1 | 10 |
|
|
| pt | principal tensile | 1 | 10 |
|
|
| pt | point-by-point technique | 1 | 9 |
|
|
| pt | parental | 1 | 9 |
|
|
| pt | performed in pre-term | 1 | 9 |
|
|
| pt | phosphinothricin | 1 | 9 |
|
|
| pt | palatine tonsils | 1 | 9 |
|
|
| pt | phosphorous compounds | 1 | 9 |
|
|
| pt | previously treated | 1 | 9 |
|
|
| pt | personalized tailored | 1 | 9 |
|
|
| pt | pathway | 1 | 9 |
|
|
| pt | prolongation of the prothrombin | 1 | 9 |
|
|
| pt | primary management of prolapsed | 1 | 9 |
|
|
| pt | partially trained condition | 1 | 9 |
|
|
| pt | posterior tibial artery | 1 | 9 |
|
|
| pt | prodrug whose active metabolite perindoprilat | 1 | 8 |
|
|
| pt | pig-tailed macaques | 1 | 8 |
|
|
| pt | permissive temperature | 1 | 8 |
|
|
| pt | pretectalis | 1 | 8 |
|
|
| pt | Porphyra tenera | 1 | 8 |
|
|
| pt | phenotype | 1 | 8 |
|
|
| pt | post-transfusional | 1 | 8 |
|
|
| pt | Parkinsonian tremor | 1 | 8 |
|
|
| pt | patellar tendon graft | 1 | 8 |
|
|
| pt | phenotype | 1 | 8 |
|
|
| pt | preservation times | 1 | 8 |
|
|
| pt | preexisting thrombus | 1 | 7 |
|
|
| pt | posterior trigone | 1 | 7 |
|
|
| pt | Po-lei tea | 1 | 7 |
|
|
| pt | parent training | 1 | 7 |
|
|
| pt | pancreolauryl test | 1 | 7 |
|
|
| pt | peak chemiluminescence | 1 | 7 |
|
|
| pt | peak amplitude | 1 | 7 |
|
|
| pt | papaverine tests | 1 | 7 |
|
|
| pt | patella tendon | 1 | 7 |
|
|
| pt | prothrombin complex | 1 | 7 |
|
|
| pt | peptidoglycan | 1 | 7 |
|
|
| pt | parameters only the depth of infiltration | 1 | 7 |
|
|
| pt | Proximal tubular pressures | 1 | 7 |
|
|
| pt | parent training program | 1 | 7 |
|
|
| pt | prognostic parameters depth of invasion | 1 | 7 |
|
|
| pt | principle ptaquiloside | 1 | 7 |
|
|
| pt | SLEV | 1 | 7 |
|
|
| pt | pyramid | 1 | 7 |
|
|
| pt | pretransfusion testing | 1 | 7 |
|
|
| pt | peripheric temperature | 1 | 7 |
|
|
| pt | perinuclear theca | 1 | 7 |
|
|
| pt | paraffin-embedded tissue | 1 | 7 |
|
|
| pt | Percent loss in twitch force | 1 | 7 |
|
|
| pt | pentaerythritol tetranitrate | 1 | 7 |
|
|
| pt | pull-through | 1 | 6 |
|
|
| pt | polymers (pT)9pA | 1 | 6 |
|
|
| pt | pressure measured directly in the trachea | 1 | 6 |
|
|
| pt | protopanaxatriol saponins | 1 | 6 |
|
|
| pt | prothrombin time test | 1 | 6 |
|
|
| pt | Proplast-Teflon | 1 | 6 |
|
|
| pt | progressive time schedule | 1 | 6 |
|
|
| pt | primary tumours | 1 | 6 |
|
|
| pt | primarily trypsinized | 1 | 6 |
|
|
| pt | postural tremor | 1 | 6 |
|
|
| pt | projected to the caudal pyramidal tract | 1 | 6 |
|
|
| pt | posterior | 1 | 6 |
|
|
| pt | pneumothorax | 1 | 6 |
|
|
| pt | panaxadiol (PD) and panaxatriol | 1 | 6 |
|
|
| pt | phenomenon "phototolerance | 1 | 6 |
|
|
| pt | phosphene threshold | 1 | 6 |
|
|
| pt | Paramecium test | 1 | 6 |
|
|
| pt | pharmacokinetic analysis of platinum | 1 | 6 |
|
|
| pt | palatine tonsil | 1 | 6 |
|
|
| pt | Periotest | 1 | 6 |
|
|
| pt | peak time | 1 | 6 |
|
|
| pt | patch testing | 1 | 6 |
|
|
| pt | phosphorus/kg | 1 | 6 |
|
|
| pt | partial-thickness | 1 | 6 |
|
|
| pt | placebo-infusion test | 1 | 6 |
|
|
| pt | pelvic tilt | 1 | 6 |
|
|
| pt | pediatric en bloc | 1 | 6 |
|
|
| pt | prophylactic treatment | 1 | 5 |
|
|
| pt | part-time | 1 | 5 |
|
|
| pt | pregnancy termination | 1 | 5 |
|
|
| pt | partial thromboplastin (PTT) and prothrombin time | 1 | 5 |
|
|
| pt | pregnant teenagers | 1 | 5 |
|
|
| pt | present in the unknown and standard | 1 | 5 |
|
|
| pt | pH in the proximal | 1 | 5 |
|
|
| pt | Pressure threshold | 1 | 5 |
|
|
| pt | pertussis tricomponent vaccine contains pertussis toxoid | 1 | 5 |
|
|
| pt | permethrin tolerance | 1 | 5 |
|
|
| pt | Percutaneous tracheostomy | 1 | 5 |
|
|
| pt | periportal thickening | 1 | 5 |
|
|
| pt | piperacillin-tazobactam | 1 | 5 |
|
|
| pt | pancreas transplantation | 1 | 5 |
|
|
| pt | polymerase I with d | 1 | 5 |
|
|
| pt | plain tablet | 1 | 5 |
|
|
| pt | pacing threshold | 1 | 5 |
|
|
| pt | previous radiotherapy and/or chemotherapy | 1 | 5 |
|
|
| pt | P/C gene-transfected | 1 | 5 |
|
|
| pt | portal vein tumor thrombus | 1 | 5 |
|
|
| pt | tolerance | 1 | 5 |
|
|
| pt | point the pain tolerance | 1 | 5 |
|
|
| pt | pyrithiamine-treated | 1 | 5 |
|
|
| pt | plastid | 1 | 4 |
|
|
| pt | prothrombin gene | 1 | 4 |
|
|
| pt | proteoglycan (PG) synthesis by peritubular | 1 | 4 |
|
|
| pt | progeny test | 1 | 4 |
|
|
| pt | Pro-Thr | 1 | 4 |
|
|
| pt | pretreating the cell with pertussis toxin | 1 | 4 |
|
|
| pt | prior treatment with pertussis toxin | 1 | 4 |
|
|
| pt | anti-pertussis toxin | 1 | 4 |
|
|
| pt | testosterone | 1 | 4 |
|
|
| pt | primary tumors | 1 | 4 |
|
|
| pt | primary | 1 | 4 |
|
|
| pt | previous antibiotics treatment | 1 | 4 |
|
|
| pt | promontory test | 1 | 4 |
|
|
| pt | physiotherapy treatment without active training | 1 | 4 |
|
|
| pt | pisotriquetral | 1 | 4 |
|
|
| pt | passive traction | 1 | 4 |
|
|
| pt | phyllodes tumors | 1 | 4 |
|
|
| pt | posterior temporal | 1 | 4 |
|
|
| pt | photon therapy | 1 | 4 |
|
|
| pt | pantethine | 1 | 4 |
|
|
| pt | pancreatic tuberculosis | 1 | 4 |
|
|
| pt | Plasma total platinum | 1 | 4 |
|
|
| pt | provides pressure-time | 1 | 3 |
|
|
| pt | pancreatic-type | 1 | 3 |
|
|
| pt | prolonged prothrombin | 1 | 3 |
|
|
| pt | Provisional type | 1 | 3 |
|
|
| pt | primary tumour size and extent | 1 | 3 |
|
|
| pt | parathyroid | 1 | 3 |
|
|
| pt | peak twitch | 1 | 3 |
|
|
| pt | prothrombin test | 1 | 3 |
|
|
| pt | promontory testing | 1 | 3 |
|
|
| pt | prostatic tissue | 1 | 3 |
|
|
| pt | patellar tendon bone autograft | 1 | 3 |
|
|
| pt | psychiatric treatment | 1 | 3 |
|
|
| pt | psychological treatment | 1 | 3 |
|
|
| pt | protein-bound platinum | 1 | 3 |
|
|
| pt | postoperative histopathological staging | 1 | 3 |
|
|
| pt | platelet transfusions | 1 | 3 |
|
|
| pt | perturbation theory | 1 | 3 |
|
|
| pt | preventive therapy | 1 | 3 |
|
|
| pt | pleural tuberculosis | 1 | 3 |
|
|
| pt | post treatment | 1 | 3 |
|
|
| pt | plasma testosterone | 1 | 3 |
|
|
| pt | pre-treatment | 1 | 3 |
|
|
| pt | pre-term | 1 | 3 |
|
|
| pt | platelets | 1 | 3 |
|
|
| pt | pulmonary thromboembolization | 1 | 2 |
|
|
| pt | positivity threshold | 1 | 2 |
|
|
| pt | phosphate | 1 | 2 |
|
|
| pt | premovement period | 1 | 2 |
|
|
| pt | Pathological tumor stages | 1 | 2 |
|
|
| pt | positron tomography | 1 | 2 |
|
|
| pt | palatal tremor | 1 | 2 |
|
|
| pt | permit the expression of pertussis toxin | 1 | 2 |
|
|
| pt | pars tuberali | 1 | 2 |
|
|
| pt | cis-platinum | 1 | 2 |
|
|
| pt | phototoxic | 1 | 1 |
|
|
| pt | protrombin time | 1 | 1 |
|
|
| pt | Physical therapists | 1 | 1 |
|
|
| pt | polyamines putrescine | 1 | 1 |
|
|
| pt | plain naproxen tablets | 1 | 1 |
|
|
| pt | patch tested | 1 | 1 |
|
|
| pt | plain tablets | 1 | 1 |
|
|
| pt | platelet transfusion | 1 | 1 |
|
|
| pt | POLAK and TURK | 1 | 1 |
|
|
| pt | phyllodes tumours | 1 | 1 |
|
|
| pt | 100-point | 1 | 1 |
|
|
| pt | platelet transfusion | 1 | 1 |
|
|
| pt | pathologic T | 1 | 1 |
|
|
| pt | peer tutoring | 1 | 1 |
|
|
| pt | polymer-tip | 1 | 1 |
|
|
| pt | Patients with acute post-transfusion | 1 | 1 |
|
|
| pt | pancreas transplants | 1 | 0 |
|
|
| pt | position test | 1 | 0 |
|
|
| pt | pituitary | 1 | 0 |
|
|
| pt | category | 1 | 0 |
|
|
| pt | perindoprilate | 1 | 0 |
|
|
| pt | Polyvinylidene Fluoride (PVDF)/Lead Titanate | 1 | 0 |
|
|
| pt | patellar tendon with bone blocks | 1 | 0 |
|
|
| pt | prolongation of twice-weekly prothrombin | 1 | 0 |
|
|
| pt | primary lesion | 1 | 0 |
|
|
| pt | permeability transition pore | 1 | 0 |
|
|
| pt | presacral teratoma | 1 | 0 |
|
|
| pt | primary tumor site | 1 | 0 |
|
|
| pt | pertussis related antigens pertussis-toxin | 1 | 0 |
|
|
| pt | premature babies | 1 | 0 |
|
|
| pt | proton transfer | 1 | 0 |
|
|
| pt | protopanaxadiol (PD) and protopanaxatriol saponins | 1 | 0 |
|
|
| pt | Painless (silent) thyroiditis | 1 | -1 |
|
|
| pt | plastic tunnels | 1 | -1 |
|
|
| pt | Phalen's test | 1 | -1 |
|
|
| pt | prognostic indicator of pathologic | 1 | -1 |
|
|
| pt | protopanaxadiol (PD) saponin and protopanaxatriol | 1 | -1 |
|
|
| pt | phenytoin | 1 | -1 |
|
|
| pt | predominant type and the pertussis toxin | 1 | -1 |
|
|
| pt | parietal bone | 1 | -1 |
|
|
| pt | peak twitch tension | 1 | -1 |
|
|
| pt | prick test | 1 | -2 |
|
|
| pt | pentostatin | 1 | -2 |
|
|
| pt | primary tumor size and extent | 1 | -2 |
|
|
| pt | peritubular | 1 | -2 |
|
|
| pt | pertussis-toxin | 1 | -2 |
|
|
| pt | phage typing | 1 | -2 |
|
|
| pt | pretectal area | 1 | -2 |
|
|
| pt | phentolamine | 1 | -2 |
|
|
| pt | parameters such as tumor stage | 1 | -2 |
|
|
| pt | prothrombin complex level | 1 | -2 |
|
|
| pt | parathyroid hormone target | 1 | -2 |
|
|
| pt | picotesla | 1 | -2 |
|
|
| pt | primary transcript | 1 | -2 |
|
Run A Search
Search either direction
By Acronym
By Full Name